| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hyperlipidemias | D006949 | 73 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Vasculitis | D014657 | 14 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Peripheral Arterial Disease | D058729 | 7 associated lipids |
| Thromboangiitis Obliterans | D013919 | 4 associated lipids |
| Bird Diseases | D001715 | 4 associated lipids |
| Obesity, Morbid | D009767 | 8 associated lipids |
| Cell Transformation, Viral | D002472 | 26 associated lipids |
lauric acid
lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.
Cross Reference
Introduction
To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with lauric acid?
lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with lauric acid
PubChem Associated disorders and diseases
What pathways are associated with lauric acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with lauric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with lauric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with lauric acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with lauric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with lauric acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with lauric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Imaoka S et al. | Induction of renal cytochrome P-450 in hepatic microsomes of diabetic rats. | 1988 | Biochem. Biophys. Res. Commun. | pmid:3365247 |
| Roomi MW et al. | Decreased expression of cytochrome P-452 in the resistance phenotype characteristic of putative preneoplastic hepatocyte nodules during hepatocarcinogenesis. | 1988 | Biochem. Biophys. Res. Commun. | pmid:3365259 |
| Kato A and Arima K | Inhibitory effect of sucrose ester of lauric acid on the growth of Escherichia coli. | 1971 | Biochem. Biophys. Res. Commun. | pmid:5543940 |
| Helvig C et al. | Drosophila melanogaster CYP6A8, an insect P450 that catalyzes lauric acid (omega-1)-hydroxylation. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15555597 |
| Russell VA et al. | Animal models of attention-deficit hyperactivity disorder. | 2005 | Behav Brain Funct | pmid:16022733 |
| Alves NF et al. | Acute Treatment with Lauric Acid Reduces Blood Pressure and Oxidative Stress in Spontaneously Hypertensive Rats. | 2017 | Basic Clin. Pharmacol. Toxicol. | pmid:28054477 |
| Stark K et al. | Expression of CYP4F12 in gastrointestinal and urogenital epithelia. | 2004 | Basic Clin. Pharmacol. Toxicol. | pmid:15078342 |
| Timbermont L et al. | Control of Clostridium perfringens-induced necrotic enteritis in broilers by target-released butyric acid, fatty acids and essential oils. | 2010 | Avian Pathol. | pmid:20390546 |
| HÃ¥versen L et al. | Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. | 2009 | Atherosclerosis | pmid:18599066 |
| Yoshida H et al. | A phosphodiesterase 3 inhibitor, K-134, improves hindlimb skeletal muscle circulation in rat models of peripheral arterial disease. | 2012 | Atherosclerosis | pmid:22269153 |
| Arrol S et al. | The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2). | 2000 | Atherosclerosis | pmid:10856517 |
| Redgrave TG and Dunne KB | Chylomicron formation and composition in unanaesthetised rabbits. | 1975 Nov-Dec | Atherosclerosis | pmid:173354 |
| Lagrost L et al. | Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. | 1999 | Atherosclerosis | pmid:10030391 |
| Hanley K et al. | Development of a plant viral-vector-based gene expression assay for the screening of yeast cytochrome p450 monooxygenases. | 2003 | Assay Drug Dev Technol | pmid:15090141 |
| Serra I et al. | Effect of dietary intake on the levels of biliary unsaturated free Fatty acids having inhibitory activity on mutagens. | 2009 | Asian Pac. J. Cancer Prev. | pmid:20104986 |
| Idris CA and Sundram K | Effect of dietary cholesterol, trans and saturated fatty acids on serum lipoproteins in non-human primates. | 2002 | Asia Pac J Clin Nutr | pmid:12492627 |
| Schlieper P and Tawfik H | Antiarrhythmic activity of alpha-tocopherol nicotinate and related compounds and their physico-chemical properties. | 1987 | Arzneimittelforschung | pmid:3675687 |
| Murai T et al. | Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits. | 1989 | Arzneimittelforschung | pmid:2510741 |
| Aoki T et al. | Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia. | 2001 | Arzneimittelforschung | pmid:11304935 |
| Imamura T et al. | Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger. | 2003 | Arzneimittelforschung | pmid:14650360 |